A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17954661.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of our study was to collect pilot data about the use of FDG PET within hours after radiofrequency ablation (RFA) of liver metastases. Total photopenia on early PET can potentially be regarded as a macroscopic tumor-free margin; focal uptake can be regarded as macroscopic residual tumor.
Medical subject headings
- Catheter Ablation
- Fluorodeoxyglucose F18
- Liver Neoplasms
- Positron-Emission Tomography